Go Pro

Best Stocks Under $10 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $10.00 (10 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Curaleaf stock logo

1. Curaleaf OTCMKTS:CURLF

$8.83 +0.09 (+1.03%)
As of 07/31/2026 03:59 PM Eastern

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. More about Curaleaf

Market Capitalization
$2.06 billion
Consensus Rating
Strong Buy
Volume
63,680 shares
Average Volume
118,719 shares
Today's Range
$8.63
$9.07
50-Day Range
$3.64
$10.92
Lynas Rare Earths stock logo

2. Lynas Rare Earths OTCMKTS:LYSDY

$9.80 -0.14 (-1.41%)
As of 07/31/2026 03:59 PM Eastern

Lynas Rare Earths Limited, together with its subsidiaries, engages in the exploration, development, mining, extraction, and processing of rare earth minerals in Australia and Malaysia. More about Lynas Rare Earths

Market Capitalization
$9.86 billion
Consensus Rating
Strong Buy
Volume
249,304 shares
Average Volume
303,183 shares
Today's Range
$9.71
$9.92
50-Day Range
$9.53
$13.80
Ur Energy stock logo

3. Ur Energy NYSEAMERICAN:URG

$1.22 -0.03 (-2.40%)
Closing price 07/31/2026 04:10 PM Eastern
Extended Trading
$1.22 0.00 (0.00%)
As of 07/31/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur Energy

Market Capitalization
$484.81 million
Consensus Rating
Buy
Consensus Price Target
$2.36 (+93.3% Upside)
Volume
7.20 million shares
Average Volume
6.33 million shares
Today's Range
$1.20
$1.27
Centrica stock logo

4. Centrica OTCMKTS:CPYYY

$8.42 +0.07 (+0.84%)
As of 07/31/2026 03:59 PM Eastern

Centrica plc operates as an integrated energy company in the United Kingdom, Ireland, Scandinavia, North America, and internationally. More about Centrica

Market Capitalization
$9.72 billion
Consensus Rating
Buy
Volume
30,041 shares
Average Volume
95,374 shares
Today's Range
$8.35
$8.47
50-Day Range
$8.28
$10.94
Ivanhoe Electric stock logo

5. Ivanhoe Electric NYSEAMERICAN:IE

$9.15 -0.20 (-2.14%)
Closing price 07/31/2026 04:10 PM Eastern
Extended Trading
$9.31 +0.16 (+1.76%)
As of 07/31/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Ivanhoe Electric Inc explores and develops metals and mineral. The company provides Typhoon data acquisition system, a geophysical system that offers primary signal. More about Ivanhoe Electric

Market Capitalization
$1.45 billion
Consensus Rating
Buy
Consensus Price Target
$17.63 (+92.6% Upside)
Volume
1.34 million shares
Average Volume
1.97 million shares
Today's Range
$8.85
$9.37
iBio stock logo

6. iBio NASDAQ:IBIO

$1.40 +0.01 (+0.72%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$1.40 +0.01 (+0.36%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

iBio, Inc, a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. More about iBio

Market Capitalization
$69.55 million
Consensus Rating
Buy
Consensus Price Target
$5.00 (+257.1% Upside)
Volume
728,592 shares
Average Volume
791,969 shares
Today's Range
$1.34
$1.47
Aclaris Therapeutics stock logo

7. Aclaris Therapeutics NASDAQ:ACRS

$5.20 -0.12 (-2.26%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$5.20 0.00 (-0.10%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Aclaris Therapeutics, Inc a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. More about Aclaris Therapeutics

Market Capitalization
$726.25 million
Consensus Rating
Buy
Consensus Price Target
$11.50 (+121.2% Upside)
Volume
1.64 million shares
Average Volume
1.65 million shares
Today's Range
$5.09
$5.34
Larimar Therapeutics stock logo

8. Larimar Therapeutics NASDAQ:LRMR

$3.82 -0.01 (-0.26%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$3.84 +0.02 (+0.52%)
As of 07/31/2026 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Larimar Therapeutics, Inc, a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. More about Larimar Therapeutics

Market Capitalization
$396.83 million
Consensus Rating
Buy
Consensus Price Target
$12.71 (+232.8% Upside)
Volume
1.06 million shares
Average Volume
1.65 million shares
Today's Range
$3.72
$3.86
Inventiva stock logo

9. Inventiva NASDAQ:IVA

$4.48 -0.14 (-3.03%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$4.47 -0.01 (-0.20%)
As of 07/31/2026 07:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. More about Inventiva

Market Capitalization
$930.53 million
Consensus Rating
Buy
Consensus Price Target
$16.56 (+269.5% Upside)
Volume
1.35 million shares
Average Volume
1.19 million shares
Today's Range
$4.34
$4.63
Uranium Royalty stock logo

10. Uranium Royalty NASDAQ:UROY

$3.40 -0.02 (-0.58%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$3.36 -0.04 (-1.32%)
As of 07/31/2026 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Uranium Royalty Corp. operates as a pure-play uranium royalty company. It acquires, accumulates, and manages a portfolio of geographically diversified uranium interests. More about Uranium Royalty

Market Capitalization
$499.21 million
P/E Ratio
170.09
Consensus Rating
Buy
Consensus Price Target
$4.13 (+21.3% Upside)
Volume
5.10 million shares
Average Volume
3.06 million shares
Nomura stock logo

11. Nomura NYSE:NMR

$9.68 +0.12 (+1.20%)
Closing price 07/31/2026 03:59 PM Eastern
Extended Trading
$9.28 -0.40 (-4.13%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nomura Holdings, Inc provides various financial services to individuals, corporations, financial institutions, governments, and governmental agencies worldwide. More about Nomura

Market Capitalization
$28.40 billion
P/E Ratio
11.25
Consensus Rating
Buy
Consensus Price Target
$10.20 (+5.4% Upside)
Volume
859,292 shares
Average Volume
1.05 million shares
Inhibikase Therapeutics stock logo

12. Inhibikase Therapeutics NASDAQ:IKT

$2.18 -0.10 (-4.39%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$2.17 -0.01 (-0.23%)
As of 07/31/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inhibikase Therapeutics, Inc, a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. More about Inhibikase Therapeutics

Market Capitalization
$287.83 million
Consensus Rating
Buy
Consensus Price Target
$5.40 (+147.7% Upside)
Volume
369,546 shares
Average Volume
994,381 shares
Today's Range
$2.13
$2.29
Red Cat stock logo

13. Red Cat NASDAQ:RCAT

$7.53 +0.15 (+2.03%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$7.48 -0.05 (-0.65%)
As of 07/31/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Red Cat Holdings, Inc engages in the provision of various products, services, and solutions to the drone industry. The company operates through two segments: Enterprise and Consumer. More about Red Cat

Market Capitalization
$924.25 million
Consensus Rating
Buy
Consensus Price Target
$21.40 (+184.2% Upside)
Volume
7.79 million shares
Average Volume
7.24 million shares
Today's Range
$7.20
$7.73
Inuvo stock logo

14. Inuvo NYSEAMERICAN:INUV

$0.92 -0.05 (-4.66%)
Closing price 07/31/2026 04:10 PM Eastern
Extended Trading
$0.92 +0.00 (+0.43%)
As of 07/31/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inuvo, Inc engages in the advertising technology and services business primarily in the United States. It sells information technology solutions to brands, agencies, and large consolidators of advertising demand (platforms). More about Inuvo

Market Capitalization
$13.64 million
Consensus Rating
Buy
Consensus Price Target
$7.33 (+697.1% Upside)
Volume
197,479 shares
Average Volume
335,039 shares
Today's Range
$0.90
$0.98
Lexeo Therapeutics stock logo

15. Lexeo Therapeutics NASDAQ:LXEO

$4.13 -0.22 (-5.06%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$3.94 -0.20 (-4.72%)
As of 07/31/2026 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Lexeo Therapeutics, Inc operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. More about Lexeo Therapeutics

Market Capitalization
$324.30 million
Consensus Rating
Buy
Consensus Price Target
$18.75 (+354.0% Upside)
Volume
713,512 shares
Average Volume
918,682 shares
Today's Range
$4.07
$4.38
Hensoldt stock logo

16. Hensoldt OTCMKTS:HAGHY

$9.16 -0.58 (-5.95%)
As of 07/31/2026 03:59 PM Eastern

HENSOLDT AG, together with its subsidiaries, provides defense and security electronic sensor solutions worldwide. It offers air surveillance, airborne, ground based, security, naval and coastal, and space radars; identification friend or foe and secure data links; and commercial shipping solutions. More about Hensoldt

Market Capitalization
$10.58 billion
Consensus Rating
Buy
Volume
119,219 shares
Average Volume
126,245 shares
Today's Range
$8.97
$9.29
50-Day Range
$7.22
$10.44
Microbot Medical stock logo

17. Microbot Medical NASDAQ:MBOT

$1.72 -0.02 (-1.15%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$1.70 -0.01 (-0.87%)
As of 07/31/2026 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. More about Microbot Medical

Market Capitalization
$115.52 million
Consensus Rating
Buy
Consensus Price Target
$6.63 (+285.2% Upside)
Volume
309,786 shares
Average Volume
529,463 shares
Today's Range
$1.68
$1.76
Orla Mining stock logo

18. Orla Mining NYSEAMERICAN:ORLA

$9.44 0.00 (0.00%)
As of 07/31/2026

Orla Mining Ltd. acquires, explores, develops, and exploits mineral properties. The company explores for gold, silver, zinc, lead, and copper deposits. More about Orla Mining

Market Capitalization
$3.27 billion
P/E Ratio
13.88
Consensus Rating
Buy
Consensus Price Target
$27.00 (+186.0% Upside)
Average Volume
2.88 million shares
Today's Range
$9.44
$9.44
Aquestive Therapeutics stock logo

19. Aquestive Therapeutics NASDAQ:AQST

$3.69 -0.03 (-0.81%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$3.68 0.00 (-0.14%)
As of 07/31/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Aquestive Therapeutics, Inc operates as a pharmaceutical company in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. More about Aquestive Therapeutics

Market Capitalization
$463.60 million
Consensus Rating
Buy
Consensus Price Target
$8.50 (+130.4% Upside)
Volume
1.79 million shares
Average Volume
1.76 million shares
Today's Range
$3.61
$3.78
Novagold Resources stock logo

20. Novagold Resources NYSEAMERICAN:NG

$5.83 -0.24 (-3.95%)
Closing price 07/31/2026 04:10 PM Eastern
Extended Trading
$5.84 +0.01 (+0.26%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NovaGold Resources Inc explores for and develops gold mineral properties in the United States. Its principal asset is the Donlin Gold project consisting of 493 mining claims covering an area of approximately 29,008 hectares located in the Kuskokwim region of southwestern Alaska. More about Novagold Resources

Market Capitalization
$2.56 billion
Consensus Rating
Buy
Consensus Price Target
$13.22 (+126.8% Upside)
Volume
3.80 million shares
Average Volume
5.04 million shares
Today's Range
$5.70
$5.97
Achieve Life Sciences stock logo

21. Achieve Life Sciences NASDAQ:ACHV

$6.42 +0.12 (+1.90%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$6.39 -0.03 (-0.40%)
As of 07/31/2026 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Achieve Life Sciences, Inc, a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. More about Achieve Life Sciences

Market Capitalization
$659.07 million
Consensus Rating
Buy
Consensus Price Target
$16.00 (+149.2% Upside)
Volume
1.18 million shares
Average Volume
1.29 million shares
Today's Range
$6.05
$6.46
Perspective Therapeutics stock logo

22. Perspective Therapeutics NYSEAMERICAN:CATX

$2.91 -0.08 (-2.68%)
Closing price 07/31/2026 04:10 PM Eastern
Extended Trading
$2.92 +0.00 (+0.17%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Perspective Therapeutics, Inc, together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. More about Perspective Therapeutics

Market Capitalization
$331.87 million
Consensus Rating
Buy
Consensus Price Target
$12.63 (+333.8% Upside)
Volume
827,579 shares
Average Volume
1.48 million shares
Today's Range
$2.83
$3.04
CytomX Therapeutics stock logo

23. CytomX Therapeutics NASDAQ:CTMX

$3.10 -0.18 (-5.49%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$3.10 +0.00 (+0.16%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CytomX Therapeutics, Inc, an oncology-focused biopharmaceutical company, focuses on developing novel conditionally activated biologics localized to the tumor microenvironment. More about CytomX Therapeutics

Market Capitalization
$527.58 million
Consensus Rating
Buy
Consensus Price Target
$12.10 (+290.3% Upside)
Volume
3.50 million shares
Average Volume
3.03 million shares
Today's Range
$3.10
$3.28
Satellogic stock logo

24. Satellogic NASDAQ:SATL

$3.58 +0.09 (+2.58%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$3.60 +0.02 (+0.50%)
As of 07/31/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Satellogic Inc operates as an integrated geospatial company in the Asia Pacific, North America, and internationally. It engages in tasking satellites with monitoring assets and keeping up with their changing reality for government and commercial customers; control satellites on top of specific areas of interest for governments; and sale and support satellites. More about Satellogic

Market Capitalization
$530.71 million
Consensus Rating
Buy
Consensus Price Target
$9.10 (+154.2% Upside)
Volume
3.58 million shares
Average Volume
4.35 million shares
Today's Range
$3.48
$3.72
Palisade Bio stock logo

25. Palisade Bio NASDAQ:PALI

$1.90 -0.07 (-3.32%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$1.88 -0.02 (-0.79%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Palisade Bio, Inc, a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. More about Palisade Bio

Market Capitalization
$328.93 million
Consensus Rating
Buy
Consensus Price Target
$9.00 (+374.9% Upside)
Volume
1.85 million shares
Average Volume
2.82 million shares
Today's Range
$1.86
$1.95